CY1117605T1 - Crohn's disease treatment with LAQUINIMOD - Google Patents

Crohn's disease treatment with LAQUINIMOD

Info

Publication number
CY1117605T1
CY1117605T1 CY20161100145T CY161100145T CY1117605T1 CY 1117605 T1 CY1117605 T1 CY 1117605T1 CY 20161100145 T CY20161100145 T CY 20161100145T CY 161100145 T CY161100145 T CY 161100145T CY 1117605 T1 CY1117605 T1 CY 1117605T1
Authority
CY
Cyprus
Prior art keywords
laquinimod
crohn
disease
treatment
disease treatment
Prior art date
Application number
CY20161100145T
Other languages
Greek (el)
Inventor
Nora Tarcic
Asi Haviv
Eran Blaugrund
Joel Kaye
Original Assignee
Teva Pharmaceutical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10804826.5A external-priority patent/EP2458992B1/en
Application filed by Teva Pharmaceutical Industries, Ltd. filed Critical Teva Pharmaceutical Industries, Ltd.
Publication of CY1117605T1 publication Critical patent/CY1117605T1/en

Links

Abstract

Αυτή η αίτηση παρέχει μία μέθοδο θεραπείας ενός ατόμου που υποφέρει από ασθένεια Crohn, όπου η μέθοδος περιλαμβάνει χορήγηση περιοδικά στο άτομο μιας ποσότητας laquinimod ή φαρμακευτικά αποδεκτού άλατος αυτού αποτελεσματικής για την θεραπεία του ατόμου. Αυτή η αίτηση παρέχει την χρήση του laquinimod στην κατασκευή ενός φαρμάκου για την θεραπεία ενός ατόμου που υποφέρει από ασθένεια Crohn. Αυτή η αίτηση παρέχει επίσης μία φαρμακευτική σύνθεση που περιλαμβάνει laquinimod για χρήση στην θεραπεία ενός ατόμου που υποφέρει από ασθένεια Crohn.This application provides a method of treating a person suffering from Crohn's disease, wherein the method comprises periodically administering to the subject a quantity of laquinimod or a pharmaceutically acceptable salt thereof effective for the treatment of the individual. This application provides the use of laquinimod in the manufacture of a medicament for the treatment of a person suffering from Crohn's disease. This application also provides a pharmaceutical composition comprising laquinimod for use in the treatment of a person suffering from Crohn's disease.

CY20161100145T 2009-07-30 2016-02-22 Crohn's disease treatment with LAQUINIMOD CY1117605T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27316709A 2009-07-30 2009-07-30
EP10804826.5A EP2458992B1 (en) 2009-07-30 2010-07-29 Treatment of crohn's disease with laquinimod

Publications (1)

Publication Number Publication Date
CY1117605T1 true CY1117605T1 (en) 2017-04-26

Family

ID=58606653

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100145T CY1117605T1 (en) 2009-07-30 2016-02-22 Crohn's disease treatment with LAQUINIMOD

Country Status (1)

Country Link
CY (1) CY1117605T1 (en)

Similar Documents

Publication Publication Date Title
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
CY1116727T1 (en) Multiple Sclerosis Treatment With LAQUINIMOD
CY1119490T1 (en) PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT
CY1124135T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ROMRE'S DISEASE
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
BR112013003677A2 (en) use of pharmacologically active agent and pharmaceutical dosage form
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
MX2014002171A (en) Combination treatments for hepatitis c.
EA201290859A1 (en) TREATMENT OF LUPUS-ARTHRITIS USING LAQUINIMODE
EA201270144A1 (en) COMBINED THERAPY FOR TREATMENT OF DIABETES
MX2012000275A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement.
EA201270071A1 (en) A METHOD OF TREATING A PATIENT NEEDING ASPIRIN TREATMENT
AR088585A1 (en) A MEDICINAL PRODUCT TO TREAT THE PREVIOUS EYE DISEASE
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
MX2022000143A (en) Novel methods.
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
EA201390618A1 (en) DOSING MODES FOR THE TREATMENT OF OPHTHALMOLOGICAL VASCULAR DISEASE
UA109359C2 (en) TREATMENT OF SKIN DISEASES AND STATES
CY1117605T1 (en) Crohn's disease treatment with LAQUINIMOD
NZ597675A (en) Medicament for the long term nsaid use
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.